SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-069123
Filing Date
2022-11-04
Accepted
2022-11-03 19:29:59
Documents
14
Period of Report
2022-10-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea167979-8k_enzobio.htm   iXBRL 8-K 41175
2 FIRST AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN ENZO BIOCHEM, INC. AND K ea167979ex10-1_enzobio.htm EX-10.1 82374
3 SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN ENZO BIOCHEM, INC. AND ea167979ex10-2_enzobio.htm EX-10.2 84562
  Complete submission text file 0001213900-22-069123.txt   431367

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enz-20221020.xsd EX-101.SCH 3212
5 XBRL LABEL FILE enz-20221020_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE enz-20221020_pre.xml EX-101.PRE 22350
8 EXTRACTED XBRL INSTANCE DOCUMENT ea167979-8k_enzobio_htm.xml XML 3593
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 221359786
SIC: 8071 Services-Medical Laboratories